Condition: Benign Prostate Obstruction (BPO) · Sponsor: University Hospital, Basel, Switzerland
This study is to assess the clinical data of Rezum (water vapor therapy) in patients with BPO (benign prostate obstruction) and male LUTS (lower urinary tract symptoms) in terms of efficacy, durability and safety in a large, prospective, multi-center cohort consisting of 1000 "real-life" patients with a follow-up of 5 years.
This description comes directly from the study's public registry record.
Niklas Simon, Study Coordinator · +41 615565616 · Niklas.Simon@usb.ch
Heike Püschel, study nurse · +41 61 556 54 77 · SteamOne.urologie@usb.ch
Always discuss trial participation with your own doctor first.
| Universitätsklinikum Graz | Graz, Austria | Active Not Recruiting |
| Alexianer St. Hedwig-Krankenhaus | Berlin, Germany | Recruiting |
| Universitätsklinikum Frankfurt | Frankfurt, Germany | Recruiting |
| Universitätsklinikum Hamburg-Eppendorf (UKE), | Hamburg, Germany | Not Yet Recruiting |
| Asklepios Westklinikum Hamburg GmbH | Hamburg, Germany | Recruiting |
| Urologische Gemeinschaftspraxis Prüner Gang | Kiel, Germany | Recruiting |
| Krankenhaus Maria Hilf - Alexianer Krefeld | Krefeld, Germany | Recruiting |
| Klinikum Nürnberg | Nuremberg, Germany | Recruiting |
| Krankenhaus Reinbek St. Adolf Stift | Reinbek, Germany | Recruiting |
| Kliniken Sindelfingen | Sindelfingen, Germany | Recruiting |
| Diakonie-Klinikum Stuttgart Diakonissenkrankenhaus und Paulinen gGmbH | Stuttgart, Germany | Not Yet Recruiting |
| Kantonsspital Aarau | Aarau, Switzerland | Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05495633